Two Sigma Investments, LP Rocket Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

$50.6 Billion
Q2 2025

A detailed history of Two Sigma Investments, LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 1,725,360 shares of RCKT stock, worth $5.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,725,360

Holding current value

$5.02 Million

% of portfolio

0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$2.33 - $8.01 $4.02 Million - $13.8 Million	1,725,360 New	1,725,360 $4.23 Million
Q4 2024 Feb 14, 2025	BUY	$11.35 - $18.82 $219,350 - $363,715	19,326 Added 88.59%	41,142 $517,000
Q3 2024 Nov 14, 2024	SELL	$17.6 - $25.88 $22,440 - $32,997	-1,275 Reduced 5.52%	21,816 $402,000
Q2 2024 Aug 14, 2024	SELL	$20.66 - $26.72 $2.62 Million - $3.39 Million	-126,917 Reduced 84.61%	23,091 $497,000
Q1 2024 May 15, 2024	SELL	$26.16 - $30.74 $2.74 Million - $3.22 Million	-104,908 Reduced 41.15%	150,008 $4.04 Million
Q4 2023 Feb 14, 2024	SELL	$16.78 - $31.94 $2.37 Million - $4.52 Million	-141,423 Reduced 35.68%	254,916 $7.64 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $5.31 Million - $8.47 Million	352,239 Added 798.73%	396,339 $8.12 Million
Q2 2023 Aug 14, 2023	SELL	$16.59 - $23.6 $1.7 Million - $2.41 Million	-102,179 Reduced 69.85%	44,100 $876,000
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $1.17 Million - $1.68 Million	74,329 Added 103.31%	146,279 $2.51 Million
Q4 2022 Feb 14, 2023	SELL	$15.5 - $22.76 $4.14 Million - $6.08 Million	-267,049 Reduced 78.78%	71,950 $1.41 Million
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $1.48 Million - $2.21 Million	120,037 Added 54.82%	338,999 $5.41 Million
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $204,476 - $427,448	-25,688 Reduced 10.5%	218,962 $3.01 Million
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $45,586 - $82,027	-3,464 Reduced 1.4%	244,650 $3.88 Million
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $865,943 - $1.45 Million	40,239 Added 19.36%	248,114 $5.42 Million
Q3 2021 Nov 15, 2021	BUY	$27.42 - $48.97 $1.08 Million - $1.92 Million	39,306 Added 23.32%	207,875 $6.21 Million
Q2 2021 Aug 16, 2021	SELL	$39.41 - $47.25 $6.41 Million - $7.69 Million	-162,717 Reduced 49.12%	168,569 $7.47 Million
Q1 2021 May 17, 2021	BUY	$43.34 - $65.91 $9.87 Million - $15 Million	227,806 Added 220.14%	331,286 $14.7 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $2.07 Million - $5.3 Million	88,973 Added 613.31%	103,480 $5.68 Million
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $173,819 - $242,414	-8,479 Reduced 36.89%	14,507 $332,000
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $306,173 - $519,713	22,986 New	22,986 $481,000

Others Institutions Holding RCKT

# of Institutions

220

Shares Held

98.3M

Call Options Held

611K

Put Options Held

487K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $220M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Rocket Pharmaceuticals, Inc. Transaction History